Recent

% | $
Quotes you view appear here for quick access.

Human Genome Sciences Inc. Message Board

  • cholee65 cholee65 Sep 12, 2011 8:53 AM Flag

    Amgen bought Oncovex for $1 billion this year.

    Amgen recently bought cancer darling Oncovex for $1 Billion. About seven years ago Genzyme
    bought San Antonio biotech Ilex Oncology for $1 Billion dollars too. It looks like if you come
    up with the good data $1 billion is the magic buyout number.If you look into the roots of who
    really created Ilex Oncology. You will find the star was Alex Weis the co-founder he was
    their scientist; he brought in two awesome drugs from Sterling in San Antonio. Now he's at it again
    with Oncovista down in San Antonio. He has a tiny market cap of $12 million and $65 million in
    milestones over next 36 months potentially. And, two drug compounds with market potential of $1.35 billion.
    If OVIT repeats Ilex Oncology's success it has 100X upside potential.

    Watch the CEO talk.. http://www.youtube.com/watch?v=Mh_RZMh-xcU

    the CEO is top notch and if their Adult Leukemia drug could have been approved for Hairy Cell Leukemia.
    However, the market was to small. I think this stock is going to be a major home run.
    This has tremendous upside potential given it's market cap is so small compared
    to all other cancer stocks listed.